Patient-derived glioblastoma stem cells respond differentially to targeted therapies

The dismal prognosis of glioblastoma is, at least in part, attributable to the difficulty in eradicating glioblastoma stem cells (GSCs). However, whether this difficulty is caused by the differential responses of GSCs to drugs remains to be determined. To address this, we isolated and characterized...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget
Hauptverfasser: Kanabur, Pratik, Guo, Sujuan, Rodgers, Cara M., Simonds, Gary R., Kelly, Deborah F., Gourdie, Robert G., Verbridge, Scott S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Impact Journals LLC 2016
Schlagworte:
Research Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5349922/
https://ncbi.nlm.nih.gov/pubmed/27863440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13415
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge